Quantcast
Channel: InnovatioNews » EMELCA Bioscience
Browsing latest articles
Browse All 2 View Live

Venaxis signs agreement with European distributor, gets first APPY1 order

CASTLE ROCK – Venaxis Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA approval for its blood-based appendicitis test, announced it has signed its first European commercial...

View Article



Venaxis expands European distribution network for APPY1 appendicitis test

CASTLE ROCK – Venaxis Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on gaining FDA approval and commercialization of its APPY1 appendicitis test, announced it has signed agreements with...

View Article
Browsing latest articles
Browse All 2 View Live




Latest Images